Study: FDG PET/CT identifies indicators of sarcoma survival

07/29/2013 | MolecularImaging.net

A study reported in the American Journal of Roentgenology revealed a connection between necrosis identified on staging F-18 FDG PET/CT in sarcoma patients, overall survival and progression-free survival. Researchers at the Royal Victoria Hospital in Montreal measured the tumor maximum standardized uptake values and the presence and volume of necrosis with follow-up data on OS and PFS in 66 patients with newly diagnosed limb and girdle sarcoma who underwent PET/CT staging. Findings revealed a connection between the presence and volume of necrosis and prognosis and mortality of sarcoma patients.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX